002755 奥赛康
已收盘 05-13 15:00:00
资讯
新帖
简况
天风证券:给予奥赛康买入评级,目标价29.35元
证券之星 · 00:45
天风证券:给予奥赛康买入评级,目标价29.35元
江苏奥赛康药业有限公司申请II类会议
金融界 · 05-09
江苏奥赛康药业有限公司申请II类会议
奥赛康(002755)4月30日股东户数1.5万户,较上期增加0.88%
证券之星 · 05-09
奥赛康(002755)4月30日股东户数1.5万户,较上期增加0.88%
5月7日奥赛康发布公告,股东减持1527.74万股
证券之星 · 05-07
5月7日奥赛康发布公告,股东减持1527.74万股
奥赛康(002755.SZ)主要股东苏洋投资减持1.50%股份
智通财经 · 05-07
奥赛康(002755.SZ)主要股东苏洋投资减持1.50%股份
奥赛康(002755)4月20日股东户数1.48万户,较上期减少9.63%
证券之星 · 05-06
奥赛康(002755)4月20日股东户数1.48万户,较上期减少9.63%
奥赛康(002755)2025年一季报简析:营收净利润同比双双增长,应收账款上升
证券之星 · 04-28
奥赛康(002755)2025年一季报简析:营收净利润同比双双增长,应收账款上升
奥赛康发布2024年年报、2025年一季报:创新转型成果彰显 高质量发展迈向新征程
中国财富通 · 04-27
奥赛康发布2024年年报、2025年一季报:创新转型成果彰显 高质量发展迈向新征程
奥赛康(002755.SZ)发布一季度业绩,归母净利润5473.03万元,同比增长73.50%
智通财经 · 04-27
奥赛康(002755.SZ)发布一季度业绩,归母净利润5473.03万元,同比增长73.50%
A股化学制药板块走高,一品红、悦康药业涨超10%,哈三联、奥赛康、益方生物、海创药业、盟科药业等跟涨。
美港电讯 · 04-14
A股化学制药板块走高,一品红、悦康药业涨超10%,哈三联、奥赛康、益方生物、海创药业、盟科药业等跟涨。
【化学制药板块走高 一品红、悦康药业涨超10%】化学制药板块走高,一品红、悦康药业涨超10%,哈三联、奥赛康、益方生物、海创药业、盟科药业等跟涨。
金融界 · 04-14
【化学制药板块走高 一品红、悦康药业涨超10%】化学制药板块走高,一品红、悦康药业涨超10%,哈三联、奥赛康、益方生物、海创药业、盟科药业等跟涨。
每周股票复盘:奥赛康(002755)股东户数增加1228户,增幅7.4%
证券之星 · 04-11
每周股票复盘:奥赛康(002755)股东户数增加1228户,增幅7.4%
3月7日奥赛康现3笔折价13.65%的大宗交易 合计成交2499.79万元
证券之星 · 03-07
3月7日奥赛康现3笔折价13.65%的大宗交易 合计成交2499.79万元
奥赛康3月7日现3笔大宗交易 成交金额2499.79万元
新浪证券-红岸工作室 · 03-07
奥赛康3月7日现3笔大宗交易 成交金额2499.79万元
3月7日奥赛康涨9.99%,创金合信医疗保健股票A基金重仓该股
证券之星 · 03-07
3月7日奥赛康涨9.99%,创金合信医疗保健股票A基金重仓该股
异动快报:奥赛康(002755)3月7日10点28分触及涨停板
证券之星 · 03-07
异动快报:奥赛康(002755)3月7日10点28分触及涨停板
奥赛康(002755)2月20日股东户数1.73万户,较上期增加9.61%
证券之星 · 03-06
奥赛康(002755)2月20日股东户数1.73万户,较上期增加9.61%
奥赛康2月27日现19笔大宗交易 成交金额7638.59万元
新浪证券-红岸工作室 · 02-27
奥赛康2月27日现19笔大宗交易 成交金额7638.59万元
加载更多
公司概况
公司名称:
北京奥赛康药业股份有限公司
所属行业:
医药制造业
上市日期:
2015-05-15
主营业务:
北京奥赛康药业股份有限公司的主营业务是原料药及制剂的研发、生产、销售。公司的主要产品是抗感染类、抗肿瘤类、慢性病类、消化类、其他类。奥赛康药业先后获得南京市市长质量奖、江苏省质量奖、全球卓越绩效奖(世界级)和中国质量奖提名奖,并获评江苏省质量信用AAA级企业、中国化学制药质量信用AAA级企业、中国医药质量管理奖、中国化学制药行业创新型优秀企业品牌、全国医药行业药品质量诚信建设示范企业、全国医药行业质量管理小组活动优秀企业等,深耕药品质量发展,坚持质量为先、品质为重。
发行价格:
7.49
{"stockData":{"symbol":"002755","market":"SZ","secType":"STK","nameCN":"奥赛康","latestPrice":17.4,"timestamp":1747119825000,"preClose":17.21,"halted":0,"volume":6343140,"delay":0,"changeRate":0.011,"floatShares":927999999,"shares":927999999,"eps":0.1977,"marketStatus":"已收盘","change":0.19,"latestTime":"05-13 15:00:00","open":17.57,"high":17.72,"low":17.2,"amount":111000000,"amplitude":0.0302,"askPrice":17.4,"askSize":53,"bidPrice":17.39,"bidSize":89,"shortable":0,"etf":0,"ttmEps":0.1977,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1747186200000},"marketStatusCode":5,"adr":0,"adjPreClose":17.21,"symbolType":"stock","openAndCloseTimeList":[[1747099800000,1747107000000],[1747112400000,1747119600000]],"highLimit":18.93,"lowLimit":15.49,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":928160351,"isCdr":false,"pbRate":5.08,"roa":"--","peRate":88.01214,"roe":"1.76%","epsLYR":0.17,"committee":0.754622,"marketValue":16150000000,"turnoverRate":0.0068,"status":0,"floatMarketCap":16150000000},"requestUrl":"/m/hq/s/002755","defaultTab":"news","newsList":[{"id":"2535737519","title":"天风证券:给予奥赛康买入评级,目标价29.35元","url":"https://stock-news.laohu8.com/highlight/detail?id=2535737519","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2535737519?lang=zh_cn&edition=full","pubTime":"2025-05-13 08:45","pubTimestamp":1747097128,"startTime":"0","endTime":"0","summary":"天风证券股份有限公司杨松近期对奥赛康进行研究并发布了研究报告《创新转型成果初现,前药平台市场潜力可观》,给予奥赛康买入评级,目标价29.35元。 奥赛康 摘要: 奥赛康主要聚焦于消化、肿瘤、耐药感染、慢性病4个治疗领域,截至2024年9月已有32个产品通过一致性评价,13个产品中标国采。奥赛康依托遮蔽肽平台,有望在实体瘤治疗领域形成差异化竞争力。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025051300005804.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002755","601162"],"gpt_icon":0},{"id":"2534621874","title":"江苏奥赛康药业有限公司申请II类会议","url":"https://stock-news.laohu8.com/highlight/detail?id=2534621874","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2534621874?lang=zh_cn&edition=full","pubTime":"2025-05-10 07:22","pubTimestamp":1746832978,"startTime":"0","endTime":"0","summary":"江苏奥赛康药业有限公司,成立于2003年,位于南京市,是一家以从事医药制造业为主的企业。通过天眼查大数据分析,江苏奥赛康药业有限公司共对外投资了13家企业,参与招投标项目3843次,知识产权方面有商标信息267条,专利信息340条,此外企业还拥有行政许可613个。主要股东信息显示,江苏奥赛康药业有限公司由北京奥赛康药业股份有限公司持股100%。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/05/10072250281719.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK0239","BK0028","002755"],"gpt_icon":0},{"id":"2534775481","title":"奥赛康(002755)4月30日股东户数1.5万户,较上期增加0.88%","url":"https://stock-news.laohu8.com/highlight/detail?id=2534775481","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2534775481?lang=zh_cn&edition=full","pubTime":"2025-05-09 17:53","pubTimestamp":1746784439,"startTime":"0","endTime":"0","summary":"证券之星消息,近日奥赛康披露,截至2025年4月30日公司股东户数为1.5万户,较4月20日增加130.0户,增幅为0.88%。在化学制药行业个股中,奥赛康股东户数低于行业平均水平,截至4月30日,化学制药行业平均股东户数为3.21万户。从股价来看,2025年4月20日至2025年4月30日,奥赛康区间涨幅为1.73%,在此期间股东户数增加130.0户,增幅为0.88%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025050900028607.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002755","BK0239","BK0028"],"gpt_icon":0},{"id":"2533984196","title":"5月7日奥赛康发布公告,股东减持1527.74万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2533984196","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2533984196?lang=zh_cn&edition=full","pubTime":"2025-05-07 20:01","pubTimestamp":1746619292,"startTime":"0","endTime":"0","summary":"证券之星消息,5月7日奥赛康发布公告《奥赛康:持股5%以上股东减持计划期限届满暨股份变动触及1%的公告》,其股东中亿伟业控股有限公司、江苏苏洋投资实业有限公司于2025年2月27日至2025年5月6日间合计减持1527.74万股,占公司目前总股本的1.646%,变动期间该股股价上涨28.35%,截止5月6日收盘报17.7元。股东增减持详情见下表:根据奥赛康2025年一季报公布的十大股东详情如下:以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025050700032503.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0028","002755"],"gpt_icon":0},{"id":"2533489981","title":"奥赛康(002755.SZ)主要股东苏洋投资减持1.50%股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2533489981","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2533489981?lang=zh_cn&edition=full","pubTime":"2025-05-07 19:49","pubTimestamp":1746618565,"startTime":"0","endTime":"0","summary":"智通财经APP讯,奥赛康(002755.SZ)发布公告,截至2025年5月6日,持股5%以上股东苏洋投资本次减持计划已期限届满,通过集中竞价和大宗交易方式累计减持公司股份1392.23万股,占公司总股本的1.50%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1290405.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"奥赛康(002755.SZ)主要股东苏洋投资减持1.50%股份","news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0239","002755","BK0028"],"gpt_icon":0},{"id":"2533083675","title":"奥赛康(002755)4月20日股东户数1.48万户,较上期减少9.63%","url":"https://stock-news.laohu8.com/highlight/detail?id=2533083675","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2533083675?lang=zh_cn&edition=full","pubTime":"2025-05-06 17:21","pubTimestamp":1746523289,"startTime":"0","endTime":"0","summary":"证券之星消息,近日奥赛康披露,截至2025年4月20日公司股东户数为1.48万户,较4月10日减少1580.0户,减幅为9.63%。在化学制药行业个股中,奥赛康股东户数低于行业平均水平,截至4月20日,化学制药行业平均股东户数为3.2万户。从股价来看,2025年4月10日至2025年4月20日,奥赛康区间涨幅为4.35%,在此期间股东户数减少1580.0户,减幅为9.63%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025050600023653.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","002755","BK0239"],"gpt_icon":0},{"id":"2531260453","title":"奥赛康(002755)2025年一季报简析:营收净利润同比双双增长,应收账款上升","url":"https://stock-news.laohu8.com/highlight/detail?id=2531260453","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2531260453?lang=zh_cn&edition=full","pubTime":"2025-04-29 06:13","pubTimestamp":1745878408,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理,近期奥赛康发布2025年一季报。截至本报告期末,公司营业总收入5.09亿元,同比上升13.39%,归母净利润5473.03万元,同比上升73.5%。本报告期奥赛康应收账款上升,应收账款同比增幅达39.89%。持有奥赛康最多的基金为鹏华医药科技股票A,目前规模为19.49亿元,最新净值1.3677,较上一交易日上涨1.44%,近一年上涨26.89%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025042900006591.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002755"],"gpt_icon":0},{"id":"2530243241","title":"奥赛康发布2024年年报、2025年一季报:创新转型成果彰显 高质量发展迈向新征程","url":"https://stock-news.laohu8.com/highlight/detail?id=2530243241","media":"中国财富通","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2530243241?lang=zh_cn&edition=full","pubTime":"2025-04-27 19:43","pubTimestamp":1745754180,"startTime":"0","endTime":"0","summary":"4月27日晚间,北京奥赛康药业股份有限公司发布2024年年度报告及2025年一季度报告。2024年,奥赛康实现营业收入17.78亿元,同比增长23.15%;归属于上市公司股东的净利润1.60亿元,同比增长207.92%;研发投入金额3.54亿元,占收入比例19.91%。奥赛康表示,2024年,创新药被国家赋予新质生产力代表的重任,同时,一系列涵盖全生命周期的政策支持体系已然成型。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://irb.cfbond.com/api/v1/detail.html?newsid=zGYAiMScP1s%3D","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0028","BK0239","002755"],"gpt_icon":0},{"id":"2530480293","title":"奥赛康(002755.SZ)发布一季度业绩,归母净利润5473.03万元,同比增长73.50%","url":"https://stock-news.laohu8.com/highlight/detail?id=2530480293","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2530480293?lang=zh_cn&edition=full","pubTime":"2025-04-27 17:09","pubTimestamp":1745744969,"startTime":"0","endTime":"0","summary":"智通财经APP讯,奥赛康(002755.SZ)发布2025年一季度报告,第一季度,公司实现营业收入5.09亿元,同比增长13.39%。归属于上市公司股东的净利润5473.03万元,同比增长73.50%。归属于上市公司股东的扣除非经常性损益的净利润4399.72万元,同比增长86.93%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1285846.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["002755"],"gpt_icon":0},{"id":"2527594614","title":"A股化学制药板块走高,一品红、悦康药业涨超10%,哈三联、奥赛康、益方生物、海创药业、盟科药业等跟涨。","url":"https://stock-news.laohu8.com/highlight/detail?id=2527594614","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2527594614?lang=zh_cn&edition=full","pubTime":"2025-04-14 09:56","pubTimestamp":1744595818,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["688658","159982","BK0239","BK1574","01477","002755","BK0028","399300","002900","BK1191","688382","300723","688373","688302"],"gpt_icon":0},{"id":"2527946700","title":"【化学制药板块走高 一品红、悦康药业涨超10%】化学制药板块走高,一品红、悦康药业涨超10%,哈三联、奥赛康、益方生物、海创药业、盟科药业等跟涨。","url":"https://stock-news.laohu8.com/highlight/detail?id=2527946700","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2527946700?lang=zh_cn&edition=full","pubTime":"2025-04-14 09:55","pubTimestamp":1744595715,"startTime":"0","endTime":"0","summary":"化学制药板块走高,一品红、悦康药业涨超10%,哈三联、奥赛康、益方生物、海创药业、盟科药业等跟涨。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/04/14095549514281.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["002900","01477","002755","688373","688658","BK1191","BK0028","688382","300723","688302","BK0239","BK1574"],"gpt_icon":0},{"id":"2526864262","title":"每周股票复盘:奥赛康(002755)股东户数增加1228户,增幅7.4%","url":"https://stock-news.laohu8.com/highlight/detail?id=2526864262","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2526864262?lang=zh_cn&edition=full","pubTime":"2025-04-12 05:30","pubTimestamp":1744407030,"startTime":"0","endTime":"0","summary":"截至2025年4月11日收盘,奥赛康报收于18.27元,较上周的18.68元下跌2.19%。本周,奥赛康4月11日盘中最高价报18.41元。奥赛康当前最新总市值169.57亿元,在化学制药板块市值排名25/152,在两市A股市值排名880/5143。本周关注点股本股东变化:截至2025年3月31日股东户数为1.78万户,较2月28日增加1228户,增幅7.4%股本股东变化近日奥赛康披露,截至2025年3月31日公司股东户数为1.78万户,较2月28日增加1228.0户,增幅为7.4%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025041200007037.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002755","BK0028"],"gpt_icon":0},{"id":"2517106973","title":"3月7日奥赛康现3笔折价13.65%的大宗交易 合计成交2499.79万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517106973","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517106973?lang=zh_cn&edition=full","pubTime":"2025-03-07 17:12","pubTimestamp":1741338728,"startTime":"0","endTime":"0","summary":"证券之星消息,3月7日奥赛康发生大宗交易,交易数据如下:近三个月该股共发生27笔大宗交易,合计成交9.28万手,折价成交27笔。该股近期无解禁股上市。截至2025年3月7日收盘,奥赛康(002755)报收于16.63元,上涨9.99%,涨停,换手率2.19%,成交量20.36万手,成交额3.3亿元。该股近半年内有股东持股变动,合计净减持1256.63万股,股东增减持明细如下表:该股最近90天内共有2家机构给出评级,买入评级2家。以上内容为证券之星据公开信息整理,由智能算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025030700029226.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002755","BK0028","BK0239"],"gpt_icon":0},{"id":"2517066081","title":"奥赛康3月7日现3笔大宗交易 成交金额2499.79万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517066081","media":"新浪证券-红岸工作室","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517066081?lang=zh_cn&edition=full","pubTime":"2025-03-07 17:00","pubTimestamp":1741338000,"startTime":"0","endTime":"0","summary":" 3月7日,奥赛康收涨9.99%,收盘价为16.63元,发生3笔大宗交易,合计成交量174.08万股,成交金额2499.79万元。 第2笔成交价格为14.36元,成交74.08万股,成交金额1,063.79万元,溢价率为-13.65%,买方营业部为机构专用,卖方营业部为华泰证券股份有限公司南京分公司。 进一步统计,近3个月内该股累计发生27笔大宗交易,合计成交金额为1.25亿元。该股近5个交易日累计上涨15.89%,主力资金合计净流入7352.9万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/ggzz/2025-03-07/doc-inenvmwk9837712.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0028","BK0239","002755"],"gpt_icon":0},{"id":"2517170878","title":"3月7日奥赛康涨9.99%,创金合信医疗保健股票A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2517170878","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517170878?lang=zh_cn&edition=full","pubTime":"2025-03-07 16:24","pubTimestamp":1741335882,"startTime":"0","endTime":"0","summary":"证券之星消息,3月7日奥赛康涨9.99%创60日新高,收盘报16.63元,换手率2.19%,成交量20.36万手,成交额3.3亿元。重仓奥赛康的前十大公募基金请见下表:该股最近90天内共有2家机构给出评级,买入评级2家。根据2024基金年报公募基金重仓股数据,重仓该股的公募基金共21家,其中持有数量最多的公募基金为创金合信医疗保健股票A。创金合信医疗保健股票A目前规模为1.46亿元,最新净值1.6012,较上一交易日上涨1.59%,近一年下跌3.9%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025030700026676.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0028","002755"],"gpt_icon":0},{"id":"2517144023","title":"异动快报:奥赛康(002755)3月7日10点28分触及涨停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2517144023","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517144023?lang=zh_cn&edition=full","pubTime":"2025-03-07 10:30","pubTimestamp":1741314644,"startTime":"0","endTime":"0","summary":"证券之星3月7日盘中消息,10点28分奥赛康(002755)触及涨停板。目前价格16.63,上涨9.99%。其所属行业化学制药目前下跌。领涨股为一品红。该股为幽门螺杆菌概念,京津冀,医药概念热股。3月6日的资金流向数据方面,主力资金净流入2322.51万元,占总成交额11.32%,游资资金净流出540.52万元,占总成交额2.63%,散户资金净流出1781.98万元,占总成交额8.68%。近5日资金流向一览见下表:奥赛康主要指标及行业内排名如下:以上内容为证券之星据公开信息整理,由智能算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025030700011832.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002755","BK0239","BK0028"],"gpt_icon":0},{"id":"2517413920","title":"奥赛康(002755)2月20日股东户数1.73万户,较上期增加9.61%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517413920","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517413920?lang=zh_cn&edition=full","pubTime":"2025-03-06 17:11","pubTimestamp":1741252305,"startTime":"0","endTime":"0","summary":"证券之星消息,近日奥赛康披露,截至2025年2月20日公司股东户数为1.73万户,较1月27日增加1517.0户,增幅为9.61%。在化学制药行业个股中,奥赛康股东户数低于行业平均水平,截至2月20日,化学制药行业平均股东户数为3.09万户。从股价来看,2025年1月27日至2025年2月20日,奥赛康区间跌幅为6.67%,在此期间股东户数增加1517.0户,增幅为9.61%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025030600029209.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0239","002755"],"gpt_icon":0},{"id":"2514753978","title":"奥赛康2月27日现19笔大宗交易 成交金额7638.59万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514753978","media":"新浪证券-红岸工作室","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514753978?lang=zh_cn&edition=full","pubTime":"2025-02-27 17:00","pubTimestamp":1740646800,"startTime":"0","endTime":"0","summary":" 2月27日,奥赛康收涨8.34%,收盘价为14.94元,发生19笔大宗交易,合计成交量580万股,成交金额7638.59万元。 第4笔成交价格为13.17元,成交50.00万股,成交金额658.50万元,溢价率为-11.85%,买方营业部为机构专用,卖方营业部为华泰证券股份有限公司南京分公司。 进一步统计,近3个月内该股累计发生19笔大宗交易,合计成交金额为7638.59万元。该股近5个交易日累计上涨16.08%,主力资金合计净流入4992.02万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/ggzz/2025-02-27/doc-inemxmaf7854899.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0239","BK0028","002755"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1747123133606,"stockEarnings":[{"period":"1week","weight":-0.0841},{"period":"1month","weight":-0.058},{"period":"3month","weight":0.3218},{"period":"6month","weight":0.3228},{"period":"1year","weight":0.5284},{"period":"ytd","weight":0.3541}],"compareEarnings":[{"period":"1week","weight":0.0275},{"period":"1month","weight":0.0405},{"period":"3month","weight":0.0154},{"period":"6month","weight":-0.0204},{"period":"1year","weight":0.0681},{"period":"ytd","weight":0.0052}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"北京奥赛康药业股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"14955人(较上一季度增加0.88%)","perCapita":"62062股","listingDate":"2015-05-15","address":"北京市丰台区南四环西路188号七区28号楼","registeredCapital":"92816万元","survey":" 北京奥赛康药业股份有限公司的主营业务是原料药及制剂的研发、生产、销售。公司的主要产品是抗感染类、抗肿瘤类、慢性病类、消化类、其他类。奥赛康药业先后获得南京市市长质量奖、江苏省质量奖、全球卓越绩效奖(世界级)和中国质量奖提名奖,并获评江苏省质量信用AAA级企业、中国化学制药质量信用AAA级企业、中国医药质量管理奖、中国化学制药行业创新型优秀企业品牌、全国医药行业药品质量诚信建设示范企业、全国医药行业质量管理小组活动优秀企业等,深耕药品质量发展,坚持质量为先、品质为重。","listedPrice":7.49},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.33.4","shortVersion":"4.33.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"奥赛康(002755)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供奥赛康(002755)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"奥赛康,002755,奥赛康股票,奥赛康股票老虎,奥赛康股票老虎国际,奥赛康行情,奥赛康股票行情,奥赛康股价,奥赛康股市,奥赛康股票价格,奥赛康股票交易,奥赛康股票购买,奥赛康股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"奥赛康(002755)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供奥赛康(002755)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}